Evidence map›Paper›PMID 27974003›Full record

ArticlePsychiatric services (Washington, D.C.)2017

The Mental Health Parity and Addiction Equity Act (MHPAEA) Evaluation Study: Impact on Quantitative Treatment Limits.

Amber Gayle Thalmayer, Sarah A Friedman, Francisca Azocar, Jessica M Harwood, Susan L Ettner

Abstract read
In one paragraph

Article in Psychiatric services (Washington, D.C.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amber Gayle ThalmayerWhen this work was done, Dr. Thalmayer was with Optum, United Health Group, Eden Prairie, Minnesota, where Dr. Azocar is affiliated. Dr. Thalmayer is now with the Institute of Psychology, University of Lausanne, Lausanne, Switzerland (e-mail: ambergayle@gmail.com ). Ms. Friedman and Dr. Ettner are with the Department of Medicine, Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, and with the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (UCLA). Ms. Harwood is with the Department of Medicine, Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA.
Sarah A FriedmanWhen this work was done, Dr. Thalmayer was with Optum, United Health Group, Eden Prairie, Minnesota, where Dr. Azocar is affiliated. Dr. Thalmayer is now with the Institute of Psychology, University of Lausanne, Lausanne, Switzerland (e-mail: ambergayle@gmail.com ). Ms. Friedman and Dr. Ettner are with the Department of Medicine, Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, and with the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (UCLA). Ms. Harwood is with the Department of Medicine, Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA.
Francisca AzocarWhen this work was done, Dr. Thalmayer was with Optum, United Health Group, Eden Prairie, Minnesota, where Dr. Azocar is affiliated. Dr. Thalmayer is now with the Institute of Psychology, University of Lausanne, Lausanne, Switzerland (e-mail: ambergayle@gmail.com ). Ms. Friedman and Dr. Ettner are with the Department of Medicine, Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, and with the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (UCLA). Ms. Harwood is with the Department of Medicine, Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA.
Jessica M HarwoodWhen this work was done, Dr. Thalmayer was with Optum, United Health Group, Eden Prairie, Minnesota, where Dr. Azocar is affiliated. Dr. Thalmayer is now with the Institute of Psychology, University of Lausanne, Lausanne, Switzerland (e-mail: ambergayle@gmail.com ). Ms. Friedman and Dr. Ettner are with the Department of Medicine, Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, and with the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (UCLA). Ms. Harwood is with the Department of Medicine, Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA.
Susan L EttnerWhen this work was done, Dr. Thalmayer was with Optum, United Health Group, Eden Prairie, Minnesota, where Dr. Azocar is affiliated. Dr. Thalmayer is now with the Institute of Psychology, University of Lausanne, Lausanne, Switzerland (e-mail: ambergayle@gmail.com ). Ms. Friedman and Dr. Ettner are with the Department of Medicine, Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, and with the Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles (UCLA). Ms. Harwood is with the Department of Medicine, Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, UCLA.

Funding

UCLA Clinical and Translational Science InstituteTL1TR000121 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$2.7M
Parity and Addiction Act: Impact on Benefits, Use and CostsR01DA032619 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ETTNER, SUSAN LOUISE · 2012 to 2015
$2.2M
The effects of three insurance benefit design features on specialty mental health utilization and expendituresR36HS024866 · AHRQ · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FRIEDMAN, SARAH A · 2016 to 2016
$39k
AHRQ HHS R36 HS024866NCATS NIH HHS TL1 TR000121NIDA NIH HHS R01 DA032619
6 · The paper itself

Abstract

objectiveThe Mental Health Parity and Addiction Equity Act (MHPAEA) significantly changed regulations governing behavioral health benefits for large, commercially insured employers. Pre-MHPAEA, many plans covered only a specific number of behavioral health treatment days or visits; post-MHPAEA, such quantitative treatment limits (QTLs) were allowed only if they were "at parity" with medical-surgical limits. This study assessed MHPAEA's effect on the prevalence of behavioral health QTLs.

methodsAnalyses used 2008-2013 specialty behavioral health benefit design data for Optum large-group plans, both carve-outs (N=2,257 plan-years, corresponding to 1,527 plans and 40 employers) and carve-ins (N=11,644 plan-years, 3,569 plans, and 340 employers). Descriptive statistics were calculated for limits existing at parity implementation, distinguished by accumulation period (annual or lifetime), level of care (inpatient, intermediate, or outpatient), unit (days, visits, or courses), condition, and network level. Proportions of plans using specific limits during the preparity (2008-2009), transition (2010), and postparity (2011-2013) periods were compared with Fisher's exact tests.

resultsPreparity, the most common QTLs were annual visit or day limits. Accounting for overlap in limit types, 89% of regular carve-out plans, 90% of in-network-only carve-outs, and 77% of carve-in plans limited outpatient visits; 66% of regular carve-out plans, 74% of in-network-only carve-outs, and 73% of carve-ins limited inpatient or intermediate days. Postparity, QTLs almost entirely disappeared (p<.001).

conclusionsBefore MHPAEA, QTLs were common. Postimplementation, virtually all plans dropped such limits, suggesting that MHPAEA was effective at eliminating QTLs. However, increasing access to behavioral health care will mean going beyond such QTL changes and looking at other areas of benefit management.

Indexed as

Health Benefit Plans, EmployeeInsurance CoverageInsurance, HealthMental Health ServicesHumansMental DisordersSubstance-Related DisordersUnited StatesBehavioral health care policyInsurance benefit designInsurance benefit mandatesInsurance parity lawsManaged careMental illness & alcohol/drug abuse

Identifiers

PMID27974003
PMCPMC5411313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.